54.28
+0.54
+(1.00%)
As of 1:08:04 PM GMT+1. Market Open.
Key Executives
Key Executives Information Not Available
Akero Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Akero Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 26, 2025 at 1:30 PM UTC - March 3, 2025 at 1:30 PM UTC
Akero Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
1U5.F Wave Life Sciences Ltd.
11.40
+2.70%
9IP1.F Rocket Pharmaceuticals, Inc.
9.94
+3.37%
GNRO.PA GeNeuro SA
0.1540
-5.81%
37Z.DU Allakos Inc
0.2329
+0.13%
SXTPW 60 Degrees Pharmaceuticals, Inc.
0.0327
-17.84%
COYA Coya Therapeutics, Inc.
5.86
+0.17%
22UA.DE BioNTech SE
118.20
-0.34%
HCWB HCW Biologics Inc.
0.2748
+6.06%
EDSA Edesa Biotech, Inc.
1.8900
+1.07%
ANIX Anixa Biosciences, Inc.
2.9400
-2.00%